Position in DHR
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$1,710,510
-$107,564 QoQ
Shares Held
8,980
-6.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#930
of 2,098 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Composition Wealth, LLC holds $8,925,074 across 7 Diagnostics & Research names. DHR ranks #3 (19.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,748 | $2,881,817 | |
| 2 | RDNT |
RadNet, Inc.
|
40,706 | $2,510,339 | |
| 3 | DHR |
Danaher Corp /De/
This page
|
8,980 | $1,710,510 | |
| 4 | DGX |
Quest Diagnostics Inc
|
2,730 | $578,623 | |
| 5 | A |
Agilent Technologies, Inc.
|
4,058 | $539,024 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
912 | $480,113 | |
| 7 | WAT |
Waters Corp /De/
|
599 | $224,648 |
All Filings in DHR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,710,510 | 8,980 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,818,074 | 9,589 | Shares | Sole | 2026-04-08 | |
| 2025-12-31 | $2,220,981 | 9,702 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $2,068,050 | 10,431 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $1,988,240 | 10,065 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $1,847,255 | 9,011 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $2,251,426 | 9,808 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $310,270 | 1,116 | Shares | Sole | 2024-10-07 | |
| 2022-03-31 | $212,664 | 725 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $4,049,783 | 12,309 | Shares | Sole | 2022-01-18 | |
| No filing history on record for this holder in this stock. | ||||||